Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin

AIMS/HYPOTHESIS: Pancreatic beta-cells retain limited ability to regenerate and proliferate after various physiologic triggers. Identifying therapies that are able to enhance beta-cell regeneration may therefore be useful for the treatment of both type 1 and type 2 diabetes. METHODS: In this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hao, Park, Soo-Young, Wang, Xiao-Jun, Misawa, Ryosuke, Grossman, Eric J., Tao, Jing, Zhong, Rong, Witkowski, Piotr, Bell, Graeme I., Chong, Anita S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675063/
https://www.ncbi.nlm.nih.gov/pubmed/23762423
http://dx.doi.org/10.1371/journal.pone.0065777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675063/
https://www.ncbi.nlm.nih.gov/pubmed/23762423
http://dx.doi.org/10.1371/journal.pone.0065777

Ejemplares similares